(Q38376498)
Statements
1 reference
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients (English)
1 reference
C Katlama
1 reference
M A Valantin
1 reference
R Bittar
1 reference
P de Truchis
1 reference
D Bollens
1 reference
L Slama
1 reference
P Giral
1 reference
D Bonnefont-Rousselot
1 reference
P Pétour
1 reference
C Aubron-Olivier
1 reference
TOTEM trial group
1 reference
6 January 2010
1 reference
1 reference
65
1 reference
3
1 reference
556-561
1 reference
Identifiers
1 reference
1 reference